Navigation Links
Wyle Engineer Inducted Into Space Technology Hall of Fame for Work on Growing Human Cells in Space
Date:4/21/2011

EL SEGUNDO, Calif., April 21, 2011 /PRNewswire/ -- A longtime engineer at Wyle's Houston-based operations has been inducted in the Space Technology Hall of Fame for his participation in developing a bioreactor, which enables the growth of tissue, cancer tumors and virus cultures outside the body, both in space and on Earth.

Dr. Tinh Trinh, a senior mechanical engineer and 26-year employee at Wyle's Integrated Science and Engineering Group supporting NASA's manned space program, was inducted during this week's 27th National Space Symposium in Colorado Springs, Colo.

Lab-grown cell cultures tend to be small, flat and two-dimensional, unlike normal cultures. But tissues grown in the bioreactor are larger and three-dimensional, with structural and chemical characteristics similar to normal tissue. And the bioreactor has no internal moving parts, thus minimizing any forces that might damage the delicate cell cultures.

The bioreactor, built by Wyle for NASA, has been used for experiments in space aboard the space shuttle, the Russian Mir Space Station and on Earth. Researchers across the United States are using this technology to study cancer, stem cells, diabetes, cartilage and nerve growth and infectious disease.

Researchers at the National Institutes of Health used the methods to propagate the human immunodeficiency virus, or HIV, in artificial lymph node tissue. This research resulted in the ability to study the virus life cycle under controlled conditions outside of the human body.

The bioreactor is a spinoff technology that made its way into the commercial world through Synthecon licensing and commercializing it in 1993. Regenetech Inc. licensed 11 patents from JSC in 2001 to produce three-dimensional tissues in the bioreactor and focused on modifications to the bioreactor to develop its own Intrifuge System and intellectual property known as CellXpansion so it could produce expanded cell tissues for specific research. This technology promises help for a wide variety of conditions, including cardiovascular disease, diabetes, skin ailments and orthopedic applications.

Regenetech provides the technology to researchers pursuing rare disease treatments. Last December Emerging Healthcare Solutions Inc. acquired a sublicense from Regenetech to use the bioreactor. The bioreactor is manufactured for commercial sale by Synthecon Inc.

The two other co-developers of the bioreactor were also inducted in the Space Technology Hall of Fame. They are Dr. David Wolf, a veteran NASA astronaut, physician, electrical engineer and former Wyle employee, and Ray Schwarz, chief engineer and co-founder of Synthecon Inc.

"We at Wyle are all tremendously proud of Tinh Trinh's role in developing this game changing technology and congratulate Tinh and his co-inventors on their award," said Bob Ellis, president of Wyle's Integrated Science and Engineering Group. "Their work, and that of the entire Wyle team, has resulted in an investment in human spaceflight to ultimately benefit medical science here on Earth."

Wyle, a privately held company, is a leading provider of high tech aerospace engineering and information technology services to the federal government on long-term outsourcing contracts. The company also provides test and evaluation of aircraft, weapon systems, networks, and other government assets; and other engineering services to the aerospace, defense, and nuclear power industries.

Contact:
Dan Reeder
(310) 563-6834
Ref.:  NR/11-14


'/>"/>
SOURCE Wyle
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. UCLA researchers now 1 step closer to controlled engineering of nanocatalysts
2. Engineering professor wins award for pioneering work expected to improve electronic devices
3. Engineers create vibrant colors in vertical silicon nanowires
4. IBM and The Institute of Bioengineering and Nanotechnology Find Breakthrough for MRSA Treatment
5. New Research Holds Promise for Gene Engineering and Therapy
6. MIT engineers devise new way to inspect materials used in airplanes
7. Princeton engineers make breakthrough in ultra-sensitive sensor technology
8. Seeing in stereo: Engineers invent lens for 3-D microscope
9. American Oriental Bioengineering Announces US$20 Million Share Repurchase Program
10. SPX Announces Acquisition of B.W. Murdoch Ltd, Broadening Process Engineering and Project Management Capabilities in New Zealand and the Asia Pacific Region
11. UT Arlington Honors Collaborative Research During March 4 Engineering Research Building Dedication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... replacement at the Caribbean Neurosciences Symposium (CANS) annual meeting in Montego Bay, Jamaica ... technology and host a hands-on workshop for surgeons to experience the simplicity of ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... endeavors to bring to market a pioneering medical device for the treatment of ... an engagement contract with Emergo, a global regulatory consultancy that helps companies like ...
(Date:1/21/2017)... 2017   Boston Biomedical , an industry leader ... cancer stemness pathways, today presented data from two clinical ... 2017 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers ... In a Phase Ib/II study of napabucasin ... cancer stemness pathways by targeting STAT3 – colorectal cancer ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
Breaking Biology Technology:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/12/2016)... Dec. 12, 2016  Researchers at Trinity College, ... graphene by combining the material with Silly Putty. The ... pressure detector able to sense pulse, blood pressure, ... spider.  The research team,s findings ... read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):